Voloridge Investment Management, LLC Cure Vac N.V. Transaction History

Voloridge Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.48 - $15.24 $327,938 - $668,152	43,842 New	43,842 $345,000
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $3.13 Million - $4.6 Million	-237,195 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $57,741 - $138,180	3,920 Added 1.68%	237,195 $4.65 Million
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $360,837 - $516,002	-10,701 Reduced 4.39%	233,275 $8 Million
Q3 2021 Nov 15, 2021	BUY	$49.26 - $74.5 $5.29 Million - $8 Million	107,363 Added 78.59%	243,976 $13.3 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $394,386 - $883,782	6,930 Added 5.34%	136,613 $10 Million
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $10.3 Million - $16.4 Million	129,683 New	129,683 $11.9 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.